Applied Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Applied Therapeutics, Inc. | APLT - NASDAQ |
$14.00-$16.00 | $10.00 | $8.04 | 4 million | 5/14/2019 |
| Citigroup, Cowen, UBS Investment Bank | ||||||
Co-Manager(s): Baird | ||||||
| Health Care | ||||||
Filing(s): Filed 2019-04-12 Terms Added 2019-04-29 | ||||||
Applied Therapeutics, Inc. Quote & Chart - Click for current quote - APLT
IPO Boutique aggregates information on public companies and private companies, such as "APLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Applied Therapeutics, Inc. (adapted from Applied Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "APLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.